The Global ambulatory infusion pumps market is projected to register a substantial CAGR of 10.4% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2019, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation:
Global Ambulatory Infusion Pumps Market, By Product Type (Devices, and Accessories and Consumables), Usage(Disposable and Reusable), Route of Administration ( Subcutaneous, Intravenous and Epidural), Application(Emergency Medicine, General Anesthesia, Pain Management, Oncology, Diabetes, Gastroenterology, Neonatology, Hematology, Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings and others),Distribution Channel (Direct Tender and Retail Sales) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the ambulatory infusion pumps are:
Rising geriatric population
Growing technological advancements in infusion pumps system
Market Players:
The key market players for the global ambulatory infusion pumps market are listed below:
B. Braun Melsungen AG
Baxter
Moog, Inc.
WalkMed
KORU Medical Systems
Intra Pump Infusion Systems
AVNS.
ICU Medical, Inc.
Eitan Medical
Fresenius Kabi (a subsidiary of Fresenius SE & Co. KGaA)
Medtronic
Micrel Medical Devices
Ace-medical
TABLE OF CONTENTS
1 INTRODUCTION 57
- 1.1 OBJECTIVES OF THE STUDY 57
- 1.2 MARKET DEFINITION 57
- 1.3 OVERVIEW OF THE GLOBAL AMBULATORY INFUSION PUMPS MARKET 57
- 1.4 LIMITATIONS 59
- 1.5 MARKETS COVERED 60
2 MARKET SEGMENTATION 63
- 2.1 MARKETS COVERED 63
- 2.2 GEOGRAPHICAL SCOPE 64
- 2.3 YEARS CONSIDERED FOR THE STUDY 65
- 2.4 CURRENCY AND PRICING 65
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 66
- 2.6 MULTIVARIATE MODELLING 69
- 2.7 PRODUCT TYPE LIFELINE CURVE 69
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 70
- 2.9 DBMR MARKET POSITION GRID 71
- 2.10 VENDOR SHARE ANALYSIS 72
- 2.11 SECONDARY SOURCES 73
- 2.12 ASSUMPTIONS 73
3 EXECUTIVE SUMMARY 74
4 PREMIUM INSIGHTS 78
- 4.1 PESTEL'S MODEL 80
- 4.2 PORTER'S FIVE FORCES 81
5 GLOBAL AMBULATORY INFUSION PUMPS MARKET: REGULATORY SCENARIO 82
6 MARKET OVERVIEW 90
- 6.1 DRIVERS 92
- 6.1.1 INCREASE IN THE GERIATRIC POPULATION 92
- 6.1.2 GROWING TECHNOLOGICAL ADVANCEMENTS IN INFUSION PUMPS SYSTEM 92
- 6.1.3 RISING DEMAND FOR AMBULATORY PUMPS IN HOME CARE SETTINGS 93
- 6.1.4 INCREASE IN THE NUMBER OF SURGERIES 93
- 6.2 RESTRAINS 93
- 6.2.1 HIGH COST LINKED WITH INFUSION PUMPS SYSTEM 93
- 6.2.2 SIDE-EFFECTS ASSOCIATED WITH INFUSION PUMPS SYSTEM 94
- 6.3 OPPORTUNITIES 95
- 6.3.1 INCREASING INCIDENCE OF CHRONIC DISEASES 95
- 6.3.2 RISING ARTIFICIAL INTELLIGENCE TO AUTOMATE DRUG INFUSIONS 95
- 6.3.3 RISING HEALTHCARE EXPENDITURE 97
- 6.3.4 INCREASED REIMBURSEMENT POLICIES 99
- 6.4 CHALLENGE 101
- 6.4.1 LACK OF SKILLED HEALTHCARE PROFESSIONALS 101
- 6.4.2 STRINGENT GOVERNMENT REGULATION 102
7 GLOBAL AMBULATORY INFUSION PUMPS MARKET, BY PRODUCT TYPE 103
- 7.1 OVERVIEW 104
- 7.2 DEVICES 107
- 7.2.1 BY PRODUCT 108
- 7.2.1.1 ELASTOMERIC PUMPS 108
- 7.2.1.1.1 MULTICHANNEL PUMP 108
- 7.2.1.1.2 SINGLE CHANNEL PUMP 108
- 7.2.1.2 ELECTRICAL PUMPS 108
- 7.2.1.2.1 MULTICHANNEL PUMP 109
- 7.2.1.2.2 SINGLE CHANNEL PUMP 109
- 7.2.1.3 MECHANICAL PUMPS 109
- 7.2.1.3.1 MULTICHANNEL PUMP 109
- 7.2.1.3.2 SINGLE CHANNEL PUMP 109
- 7.2.1.4 OTHER PUMPS 110
- 7.2.2 BY MODALITY 110
- 7.2.2.1 PORTABLE 110
- 7.2.2.2 WEARABLE 110
- 7.3 ACCESSORIES AND CONSUMABLES 110
- 7.3.1 IV/ADMINISTRATION SETS 111
- 7.3.2 TUBING & EXTENSION 111
- 7.3.3 INFUSION CATHETERS 111
- 7.3.4 INSULIN RESERVOIR OR CARTRIDGES 112
- 7.3.5 CANNULAS 112
- 7.3.6 NEEDLELESS CONNECTORS 112
- 7.3.7 BATTERY 112
- 7.3.8 OTHERS 112
8 GLOBAL AMBULATORY INFUSION PUMPS MARKET, BY USAGE 113
- 8.1 OVERVIEW 114
- 8.1.1 DISPOSABLE 116
- 8.1.2 DEVICES 117
- 8.1.3 ACCESSORIES AND CONSUMABLES 117
- 8.2 REUSABLE 117
- 8.2.1 DEVICES 118
- 8.2.2 ACCESSORIES AND CONSUMABLES 118
9 GLOBAL AMBULATORY INFUSION PUMPS MARKET, BY ROUTE OF ADMINISTRATION 119
- 9.1 OVERVIEW 120
- 9.2 INTRAVENOUS 122
- 9.3 SUBCUTANEOUS 123
- 9.4 EPIDURAL 123
10 GLOBAL AMBULATORY INFUSION PUMPS MARKET, BY APPLICATION 125
- 10.1 OVERVIEW 126
- 10.2 PAIN MANAGEMENT 128
- 10.2.1 DEVICES 129
- 10.2.2 ACCESSORIES AND CONSUMABLES 129
- 10.3 DIABETES 129
- 10.3.1 DEVICES 130
- 10.3.2 ACCESSORIES AND CONSUMABLES 130
- 10.4 ONCOLOGY 130
- 10.4.1 DEVICES 131
- 10.4.2 ACCESSORIES AND CONSUMABLES 131
- 10.5 NEONATOLOGY 131
- 10.5.1 DEVICES 132
- 10.5.2 ACCESSORIES AND CONSUMABLES 132
- 10.6 GASTROENTEROLOGY 132
- 10.6.1 DEVICES 133
- 10.6.2 ACCESSORIES AND CONSUMABLES 133
- 10.7 GENERAL ANESTHESIA 134
- 10.7.1 DEVICES 134
- 10.7.2 ACCESSORIES AND CONSUMABLES 134
- 10.8 EMERGENCY MEDICINE 135
- 10.8.1 DEVICES 135
- 10.8.2 ACCESSORIES AND CONSUMABLES 135
- 10.9 OTHERS 136
11 GLOBAL AMBULATORY INFUSION PUMPS MARKET, BY END USER 137
- 11.1 OVERVIEW 138
- 11.2 HOSPITALS 140
- 11.3 HOMECARE SETTINGS 141
- 11.4 AMBULATORY SURGICAL CENTERS 141
- 11.5 SPECIALTY CLINICS 142
- 11.6 OTHERS 142
12 GLOBAL AMBULATORY INFUSION PUMPS MARKET, BY DISTRIBUTION CHANNEL 144
- 12.1 OVERVIEW 145
- 12.2 DIRECT TENDER 147
- 12.3 RETAIL SALES 148
13 GLOBAL AMBULATORY INFUSION PUMPS MARKET, BY REGION 149
- 13.1 OVERVIEW 150
- 13.2 NORTH AMERICA 155
- 13.2.1 U.S. 166
- 13.2.2 CANADA 173
- 13.2.3 MEXICO 180
- 13.3 EUROPE 187
- 13.3.1 GERMANY 198
- 13.3.2 FRANCE 205
- 13.3.3 U.K. 212
- 13.3.4 ITALY 219
- 13.3.5 RUSSIA 226
- 13.3.6 SPAIN 233
- 13.3.7 TURKEY 240
- 13.3.8 NETHERLANDS 247
- 13.3.9 SWITZERLAND 254
- 13.3.10 BELGIUM 261
- 13.3.11 REST OF EUROPE 268
- 13.4 ASIA-PACIFIC 269
- 13.4.1 CHINA 280
- 13.4.2 JAPAN 287
- 13.4.3 SOUTH KOREA 294
- 13.4.4 INDIA 301
- 13.4.5 AUSTRALIA 308
- 13.4.6 SINGAPORE 315
- 13.4.7 THAILAND 322
- 13.4.8 MALAYSIA 329
- 13.4.9 INDONESIA 336
- 13.4.10 PHILIPPINES 343
- 13.4.11 REST OF ASIA-PACIFIC 350
- 13.5 SOUTH AMERICA 351
- 13.5.1 BRAZIL 362
- 13.5.2 ARGENTINA 369
- 13.5.3 REST OF SOUTH AMERICA 376
- 13.6 MIDDLE EAST AND AFRICA 377
- 13.6.1 SOUTH AFRICA 388
- 13.6.2 SAUDI ARABIA 395
- 13.6.3 UAE 402
- 13.6.4 EGYPT 409
- 13.6.5 ISRAEL 416
- 13.6.6 REST OF MIDDLE EAST AND AFRICA 423
14 GLOBAL AMBULATORY INFUSION PUMPS MARKET: COMPANY LANDSCAPE 424
- 14.1 COMPANY SHARE ANALYSIS: GLOBAL 424
- 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 425
- 14.3 COMPANY SHARE ANALYSIS: EUROPE 426
- 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 427
15 SWOT ANALYSIS 428
16 COMPANY PROFILE 429
- 16.1 MEDTRONIC 429
- 16.1.1 COMPANY SNAPSHOT 429
- 16.1.2 REVENUE ANALYSIS 429
- 16.1.3 COMPANY SHARE ANALYSIS 430
- 16.1.4 PRODUCT PORTFOLIO 430
- 16.1.5 RECENT DEVELOPMENT 430
- 16.2 ICU MEDICAL 431
- 16.2.1 COMPANY SNAPSHOT 431
- 16.2.2 REVENUE ANALYSIS 431
- 16.2.3 PRODUCT PORTFOLIO 432
- 16.2.4 RECENT DEVELOPMENTS 432
- 16.3 BAXTER 433
- 16.3.1 COMPANY SNAPSHOT 433
- 16.3.2 REVENUE ANALYSIS 433
- 16.3.3 COMPANY SHARE ANALYSIS 434
- 16.3.4 PRODUCT PORTFOLIO 434
- 16.3.5 RECENT DEVELOPMENT 434
- 16.4 B. BRAUN MELSUNGEN AG 435
- 16.4.1 COMPANY SNAPSHOT 435
- 16.4.2 REVENUE ANALYSIS 435
- 16.4.3 COMPANY SHARE ANALYSIS 436
- 16.4.4 PRODUCT PORTFOLIO 436
- 16.4.5 RECENT DEVELOPMENTS 437
- 16.5 FRESENIUS KABI AG (SUBSIDIARY OF FRESENIUS SE & CO.KGAA) 438
- 16.5.1 COMPANY SNAPSHOT 438
- 16.5.2 REVENUE ANALYSIS 438
- 16.5.3 COMPANY SHARE ANALYSIS 439
- 16.5.4 PRODUCT PORTFOLIO 439
- 16.5.5 RECENT DEVELOPMENTS 439
- 16.6 BD 440
- 16.6.1 COMPANY SNAPSHOT 440
- 16.6.2 REVENUE ANALYSIS 440
- 16.6.3 PRODUCT PORTFOLIO 441
- 16.6.4 RECENT DEVELOPMENT 441
- 16.7 ACE-MEDICAL 442
- 16.7.1 COMPANY SNAPSHOT 442
- 16.7.2 PRODUCT PORTFOLIO 442
- 16.7.3 RECENT DEVELOPMENTS 442
- 16.8 AVNS. 443
- 16.8.1 COMPANY SNAPSHOT 443
- 16.8.2 PRODUCT PORTFOLIO 443
- 16.8.3 RECENT DEVELOPMENT 443
- 16.9 EITAN MEDICAL 444
- 16.9.1 COMPANY SNAPSHOT 444
- 16.9.2 PRODUCT PORTFOLIO 444
- 16.9.3 RECENT DEVELOPMENT 444
- 16.10 INTRA PUMP INFUSION SYSTEMS. 445
- 16.10.1 COMPANY SNAPSHOT 445
- 16.10.2 PRODUCT PORTFOLIO 445
- 16.10.3 RECENT DEVELOPMENT 445
- 16.11 KORU MEDICAL SYSTEMS 446
- 16.11.1 COMPANY SNAPSHOT 446
- 16.11.2 PRODUCT PORTFOLIO 446
- 16.11.3 RECENT DEVELOPMENT 446
- 16.12 MOOG INC 447
- 16.12.1 COMPANY SNAPSHOT 447
- 16.12.2 REVENUE ANALYSIS 447
- 16.12.3 PRODUCT PORTFOLIO 448
- 16.12.4 RECENT DEVELOPMENT 448
- 16.13 MICREL MEDICAL DEVICES SA 449
- 16.13.1 COMPANY SNAPSHOT 449
- 16.13.2 PRODUCT PORTFOLIO 449
- 16.13.3 RECENT DEVELOPMENTS 449
- 16.14 WALKMED 450
- 16.14.1 COMPANY SNAPSHOT 450
- 16.14.2 PRODUCT PORTFOLIO 450
- 16.14.3 RECENT DEVELOPMENT 450
- 16.15 WOODLEY EQUIPMENT COMPANY LTD 451
- 16.15.1 COMPANY SNAPSHOT 451
- 16.15.2 PRODUCT PORTFOLIO 451
- 16.15.3 RECENT DEVELOPMENT 451
17 QUESTIONNAIRE 452
18 RELATED REPORTS 456